Ulcerative colitis is a chronic intestinal disease of multifactorial etiology produced by interaction between the microbiome, genetic, environmental and immunological factors. It is also called Inflammatory bowel disease (IBD) which leads to decreased health‐related quality of life and work productivity. In this case, research concentrates on enhancing treatment approaches, with a designed tactic to improve patient outcomes, reduce reappearance, and improve the quality of life for the patients dealing with Ulcerative Colitis.